The Central Drugs Standard Control Organisation (CDSCO) has approved AstraZeneca Pharma India's application to import and distribute Enhertu (trastuzumab deruxtecan) for the treatment of HER2-positive breast cancer, marking a significant…
The Central Drugs Standard Control Organisation (CDSCO) has been steadily tightening India's drug manufacturing quality standards through the revised Schedule M of the Drugs and Cosmetics Rules. For pharmaceutical manufacturers,…
The Central Drugs Standard Control Organisation (CDSCO) has signalled a major shift in India’s drug regulatory framework, moving toward a risk-based approach designed to reduce compliance burdens for pharmaceutical manufacturers…
Buying generic medicines in India can save significant money — but quality varies widely between manufacturers. According to the World Health Organization (WHO), generic medicines should be bioequivalent to their…